These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 23012396)

  • 1. Effects of perilipin 2 antisense oligonucleotide treatment on hepatic lipid metabolism and gene expression.
    Imai Y; Boyle S; Varela GM; Caron E; Yin X; Dhir R; Dhir R; Graham MJ; Ahima RS
    Physiol Genomics; 2012 Nov; 44(22):1125-31. PubMed ID: 23012396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perilipin-2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra-hepatocyte actions.
    Orlicky DJ; Libby AE; Bales ES; McMahan RH; Monks J; La Rosa FG; McManaman JL
    J Physiol; 2019 Mar; 597(6):1565-1584. PubMed ID: 30536914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of hepatosteatosis and lipid levels by an adipose differentiation-related protein antisense oligonucleotide.
    Imai Y; Varela GM; Jackson MB; Graham MJ; Crooke RM; Ahima RS
    Gastroenterology; 2007 May; 132(5):1947-54. PubMed ID: 17484887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perilipin-2 Deletion Impairs Hepatic Lipid Accumulation by Interfering with Sterol Regulatory Element-binding Protein (SREBP) Activation and Altering the Hepatic Lipidome.
    Libby AE; Bales E; Orlicky DJ; McManaman JL
    J Biol Chem; 2016 Nov; 291(46):24231-24246. PubMed ID: 27679530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of perilipin 2 prevents hepatic steatosis, glucose intolerance and ceramide accumulation in alcohol-fed mice.
    Carr RM; Peralta G; Yin X; Ahima RS
    PLoS One; 2014; 9(5):e97118. PubMed ID: 24831094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice.
    Yu XX; Murray SF; Pandey SK; Booten SL; Bao D; Song XZ; Kelly S; Chen S; McKay R; Monia BP; Bhanot S
    Hepatology; 2005 Aug; 42(2):362-71. PubMed ID: 16001399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A missense variant in human perilipin 2 (
    Scorletti E; Saiman Y; Jeon S; Schneider CV; Buyco DG; Lin C; Himes BE; Mesaros CA; Vujkovic M; Creasy KT; Furth EE; Billheimer JT; Hand NJ; Kaplan DE; Chang KM; Tsao PS; Lynch JA; Dempsey JL; Harkin J; Bayen S; Conlon D; Guerraty M; Phillips MC; Rader DJ; Carr RM
    JHEP Rep; 2024 Jan; 6(1):100902. PubMed ID: 38074507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted Delivery of Stk25 Antisense Oligonucleotides to Hepatocytes Protects Mice Against Nonalcoholic Fatty Liver Disease.
    Cansby E; Nuñez-Durán E; Magnusson E; Amrutkar M; Booten SL; Kulkarni NM; Svensson LT; Borén J; Marschall HU; Aghajan M; Mahlapuu M
    Cell Mol Gastroenterol Hepatol; 2019; 7(3):597-618. PubMed ID: 30576769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated Action of Autophagy and Adipose Tissue Triglyceride Lipase Ameliorates Diet-Induced Hepatic Steatosis in Liver-Specific PLIN2 Knockout Mice.
    Griffin JD; Bejarano E; Wang XD; Greenberg AS
    Cells; 2021 Apr; 10(5):. PubMed ID: 33923083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents.
    Vatner DF; Goedeke L; Camporez JG; Lyu K; Nasiri AR; Zhang D; Bhanot S; Murray SF; Still CD; Gerhard GS; Shulman GI; Samuel VT
    Diabetologia; 2018 Jun; 61(6):1435-1446. PubMed ID: 29497783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of TIP47 improves hepatic steatosis and glucose homeostasis in mice.
    Carr RM; Patel RT; Rao V; Dhir R; Graham MJ; Crooke RM; Ahima RS
    Am J Physiol Regul Integr Comp Physiol; 2012 Apr; 302(8):R996-1003. PubMed ID: 22378776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perilipin-2 Modulates Lipid Absorption and Microbiome Responses in the Mouse Intestine.
    Frank DN; Bales ES; Monks J; Jackman MJ; MacLean PS; Ir D; Robertson CE; Orlicky DJ; McManaman JL
    PLoS One; 2015; 10(7):e0131944. PubMed ID: 26147095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Rab18 on liver injury and lipid accumulation by regulating perilipin 2 and peroxisome proliferator-activated receptor gamma in non-alcoholic fatty liver disease.
    Zhang L; Xu L; Rong A; Cui Y; Wang L; Li L; Han X; Xiao X; Wu H
    J Gastroenterol Hepatol; 2024 Oct; 39(10):2219-2227. PubMed ID: 39030773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiting monoacylglycerol acyltransferase 1 ameliorates hepatic metabolic abnormalities but not inflammation and injury in mice.
    Soufi N; Hall AM; Chen Z; Yoshino J; Collier SL; Mathews JC; Brunt EM; Albert CJ; Graham MJ; Ford DA; Finck BN
    J Biol Chem; 2014 Oct; 289(43):30177-88. PubMed ID: 25213859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second-generation antisense oligonucleotides against β-catenin protect mice against diet-induced hepatic steatosis and hepatic and peripheral insulin resistance.
    Popov VB; Jornayvaz FR; Akgul EO; Kanda S; Jurczak MJ; Zhang D; Abudukadier A; Majumdar SK; Guigni B; Petersen KF; Manchem VP; Bhanot S; Shulman GI; Samuel VT
    FASEB J; 2016 Mar; 30(3):1207-17. PubMed ID: 26644352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of ADRP prevents diet-induced insulin resistance.
    Varela GM; Antwi DA; Dhir R; Yin X; Singhal NS; Graham MJ; Crooke RM; Ahima RS
    Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G621-8. PubMed ID: 18669627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis.
    Najt CP; Senthivinayagam S; Aljazi MB; Fader KA; Olenic SD; Brock JR; Lydic TA; Jones AD; Atshaves BP
    Am J Physiol Gastrointest Liver Physiol; 2016 May; 310(9):G726-38. PubMed ID: 26968211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Periostin antisense oligonucleotide prevents hepatic steatosis and fibrosis in a mouse model of non-alcoholic steatohepatitis.
    Kobayashi T; Kanno K; Nguyen PT; Sugiyama A; Kawahara A; Otani Y; Kishikawa N; Ito M; Tazuma S
    J Gastroenterol Hepatol; 2020 Dec; 35(12):2140-2150. PubMed ID: 32365405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel role for ceramide synthase 6 in mouse and human alcoholic steatosis.
    Williams B; Correnti J; Oranu A; Lin A; Scott V; Annoh M; Beck J; Furth E; Mitchell V; Senkal CE; Obeid L; Carr RM
    FASEB J; 2018 Jan; 32(1):130-142. PubMed ID: 28864659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactive Oxygen Species Induces Lipid Droplet Accumulation in HepG2 Cells by Increasing Perilipin 2 Expression.
    Jin Y; Tan Y; Chen L; Liu Y; Ren Z
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.